Whereas our approach to the study of PRRs can in principle be pursued for any transcription factor of interest, we reasoned that AR and ER in the context of prostate and breast cancer cells would provide an excellent proof of principle as both diseases are characterized by a prominent hereditary component and as alternative roles for AR and ER have been suggested for both diseases. The gene discussed is AR; the disease is breast carcinoma.